Attention-deficit/hyperactivity disorder: A neuropsychiatric disorder with childhood onset

European Journal of Paediatric Neurology

Volumn 4, Issue 2, 2000, Pages 53-62

  Zuddas, Alessandro ^a   Ancilletta, Bernadette ^a   Muglia, Pierandrea ^a   Cianchetti, Carlo ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Attention deficit; Hyperactivity; Hyperactivity disorder

Indexed keywords

ALCOHOL; ALPHA 2 ADRENERGIC RECEPTOR; CARBAMAZEPINE; CATECHOLAMINE; CLONIDINE; DEXAMPHETAMINE; DOPAMINE; DOPAMINE RECEPTOR; GROWTH HORMONE; GUANFACINE; ILLICIT DRUG; METHYLPHENIDATE; NEUROTRANSMITTER; PEMOLINE; PHENOBARBITAL; PROTEIN KINASE (CALCIUM,CALMODULIN) II; PSYCHOSTIMULANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ATTENTION DEFICIT DISORDER; BEHAVIOR MODIFICATION; BEHAVIOR THERAPY; BRAIN; COGNITIVE THERAPY; COMORBIDITY; DIFFERENTIAL DIAGNOSIS; FAMILY THERAPY; GENE; GENETIC PREDISPOSITION; HEADACHE; HUMAN; INSOMNIA; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SOCIAL PSYCHOLOGY; STOMACH PAIN;

EID: 0034162269     PISSN: 10903798     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejpn.1999.0263     Document Type: Review

References (89)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 4th Edn (DSM-IV). Washington, DC: American Psychiatric Association, 1994.
2. Cantwell DP. Attention deficit disorder: A review of the past 10 years. J Am Acad Child Adolesc Psychiat 1996; 35: 978-987.
3. Barkley RA, Fischer M, Edelbroch CS, Smallish L. The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up. J Am Acad Child Adolesc Psychiat 1990; 29: 546-557.
4. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines 10th Revision. Geneva: World Health Organization, 1992.
5. Swanson JM, Sergeant JA, Taylor E et al. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 1998; 351: 429-433.
6. Swanson J, Castellanos FX, Murias M et al. Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder. Curr Opin Neurobiol 1998; 8: 263-271.
7. Tannock R. Attention deficit hyperactivity disorder: Advance in cognitive, neurobiological, and genetic research. J Child Psychol Psychiat 1998; 39: 65-99.
8. Rapoport JL, Castellanos FX. Attention deficit hyperactivity disorder. In: Weiner JM (ed) Diagnosis and Psychopharmacology of Childhood and Adolescent Disorders, 2nd Edn. New York: Wiley & Son. 1996: 265-280.
9. Baumgaertel A, Wolraich ML, Dietrich M. Comparison of diagnostic criteria for attention deficit disorders in a German elementary school sample. J Am Acad Child Adolesc Psychiat 1995; 34: 629-638.
10. Wolraich ML, Hannah JN, Pinnock TY et al. Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a country-wide sample. J Am Acad Child Adolesc Psychiat 1996; 35: 319-324.
11. Szatmari P, Offord DR, Boyle MH. Ontario child health study: Prevalence of attention deficit disorder with hyperactivity. J Child Psychol Psychiat 1989; 30: 219-230
12. Gallucci F, Bird HR, Berardi C et al. Symptoms of attention deficit hyperactivity disorder in an Italian school sample: Finding of a pilot study. J Am Acad Child Adolesc Psychiat 1993; 32: 1051-1058.
13. Corkun P, Tannock R, Moldofsky H. Sleep disturbances in children with attention deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiat 1998, 37: 637-646.
14. Jensen PS, Martin BA, Cantwell DP. Comorbidity in ADHD: Implications for research, practice, and DSM-IV. J Am Acad Child Adolesc Psychiat 1997; 36: 1065-1079.
15. Newcorn J, Halperin JM. Comorbidity among disruptive behavior disorders: Impact on severity, impairment, and response to treatment. Child Adolesc Psychiat Clin North Am 1994; 3: 227-252
16. Pliszka SR. Effects of anxiety on cognition, behavior and stimulant response in ADHD. J Am Acad Child Adolesc Psychiat 1989; 28: 882-887.
17. Tannock R, Ickowicz A, Schachar RJ. Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. J Am Acad Child Adolesc Psychiat 1995; 34: 886-896.
18. Diamond IR, Tannock R, Schachar RJ. Responce of methylphenidate in children with ADHD and comorbid anxiety. J Am Acad Child Adolesc Psychiat 1999; 38: 402-409.
19. Chang HT, Klorman R, Shaywitz SE et al. Paired-associate learning in attention-deficit/hyperactivity disorder as a function of hyperactivity-impulsivity and oppositional defiant disorder. J Abnorm Child Psychol 1999, 27: 237-245.
20. Shaywitz BA, Flecher JM, Shaywitz SE. Attention-deficit/hyperactivity disorder. Adv Pediat 1997; 44: 331-367
21. Shaywitz BA, Flecher JM, Holahan JM et al. Cognitive profile of reading disability. Interrelationships between reading disability and attention-deficit/hyperactivity disorder. Clin Neuropsychol 1995; 1: 170-186.
22. Purvis KL, Tannock R. Language abilities in children with attention-deficit hyperactivity disorder, reading disabilities and normal controls. J Abnorm Child Psychol 1997; 25: 133-144.
23. Posner MI, Peterson SE. The attention system of the human brain. Ann Rev Neurosci 1990; 13: 25-42.
24. Singer HS, Brown J, Quaskey S, et al. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: A double-blind placebo-controlled study with clonidine and desipramine. Pediatrics 1995; 95: 74-81.
25. Pliska SR, McCracken JT, Maas JW. Cathecholamines in attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiat 1996; 35: 264-272.
26. Thierry AM, Mantz J, Glowinski J. Influence of dopaminergic and noradrenergic afferents on their target cells in the rat medial prefrontal cortex. Adv Neurol 1992; 57: 545-554.
27. Goldman-Rakic PS. Dopamine mediated mechanism of prefrontal cortex. Semin Neurosci 1992; 4: 149-159.
28. Gainetdinov RR, Wetsel WC, Jones SR et al. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 1999; 283: 397-401.
29. Quay HC. Inhibition and attention deficit hyperactivity disorder. J Child Psychol. Psychiat 1997; 25: 7-13.
30. Barkley RA. Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychol Bull 1997; 121: 65-94.
31. Sonuga-Barke EJS, Williams E, Hall M, Saxton T. Hyperactivity and delay aversion. III: The effects on cognitive style of imposing delay after errors. J Child Psychol Psychiat 1996; 37: 189-194.
32. Sergeant JA, Oosterlaan J, Van der Meere JJ. Information processing and energetic factors in attention-deficit/hyperactivity disorder. In: Quay HC (ed) Hogan Handbook of Disruptive Behavior Disorders. New York: Plenum Press, 1999: 74-104.
33. Castellanos FX, Lau E, Tayebi N et al. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiat 1996; 53: 607-616.
34. Casey BJ, Castellanos FX, Giedd JN et al. Implication of right frontostriatal circuitry in response inhibition and attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiat 1997; 36: 374-383.
35. Filipek PA, Semrud-Clikeman M, Steingard RJ et al. Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 1997; 48: 589-601.
36. Mataro M, Garcia-Sancuez C, Junque C et al. Magnetic resonance imaging measurement of the caudate nucleus in adolescents with attention-deficit hyperactivity disorder and its relationship with neuropsychological and behavioral measures. Arch Neurol 1997; 54: 963-968.
37. Amen DG, Carmichael BD. High resolution brain SPECT imaging in ADHD. Ann Clin Psychiat 1997; 9: 81-86.
38. Lou HC, Andresen J, Steinberg B et al. The striatum in a putative cerebral network activated by verbal awareness in normal and ADHD children. Eur J Neurol 1998; 5: 67-64.
39. Zametkin AJ, Nordahl TE, Gross M et al. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med 1990; 8: 377-338
40. Ernst M, Zametkin AJ, Matochik JA et al. DOPA decarboxylase activity in attention defict hyperactivity disorder adults. A (florine 18)fluordopa positron emission tomographic study. J Neuroscience 1998; 18: 5901-5907.
41. Volkow ND, Wang GJ, Fowler JS et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiat 1998; 155: 1325-1331.
42. Silberstain RB, Farow M, Levy F et al. Functional brain electrical activity mapping in boys with attention deficit disorder Arc Gen Psychiat 1998; 55: 1105-1112.
43. Vaidya CJ, Austin G, Kirkorian G et al. Selective effects of methylphenidate in attention deficit disorder: A functional magnetic resonance study. Proc Natl Acad Sci USA 1998; 95: 14494-14499.
44. Castellanos FX, Lau E, Tayebi N et al. Lack of association between a dopamine 4 receptor polymorphism and attention deficit/hyperactivity disorder. Mol Psychiat 1998; 3: 431-434.
45. Cook EH, Stein MA, Krasowski MD, et al. Association of attention deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995; 56: 993-998.
46. LaHoste GJ, Swanson JM, Wigal SB, et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiat 1996; 1: 121-124.
47. Smalley SL, Bailey JN, Palmer CG et al. Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder. Mol Psychiat 1998; 3: 427-430.
48. Waldman ID, Rowe DC, Abramowitz A et al. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: Heterogeneity owing to diagnostic subtype and severity. Am J Hum Genet 1998; 63: 1767-1776.
49. Sagvolden T, Metger MA, Schiorbeck HK et al. The spontaneous hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): Changed reactivity to reinforcers and to psychomotor stimulants. Behav Neurol Biol 1992; 58: 103-112.
50. Carey MP, Diewald L, Papa M et al. Differential distribution of D-1 and D-2 dopamine receptors in the target sites of the mesolimbic system in an animal model of ADHD. Behav Brain Res 1998; 94: 173-185.
51. Papa M, Sagvolden T, Sergeant JA, Sadile AG. Reduced CaMKII-positive neurones in the accumbal shell of an animal model of attention-deficit hyperactivity disorder. Neuroreport 1996; 7: 3017-3020.
52. Papa M, Berger DF, Sagvolden T et al. A quantitative cytochrome oxidase mapping study, cross-regional and neurobehavioural correlations in the anterior forebrain of an animal model of attention deficit hyperactivity disorder. Behav Brain Res 1998; 94: 197-211.
53. Conners K. Conners Rating Scales (Revised), Toronto, Canada: Multi Health Systems Inc, 1997.
54. Biederman J, Klein RG, Pine DS, Klein DF. Resolved: Mania is mistaken for ADHD in prepuberal children. J Am Acad Child Adolesc Psychiat 1998; 37: 1091-1099.
55. Biederman J, Faraone SV, Milberger S et al. Predictors of persistence and remission of ADHD into adolescence: Results from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiat 1996; 35: 343-351.
56. Gittelman R, Mannuzza S, Shenker R, Bonagyura N. Hyperactive boys almost grown up: I. Psychiatric status. Arch Gen Psychiat 1985; 42: 937-947.
57. Taylor E, Chadwick O, Heptinstall E, Danckaerts M. Hyperactivity and conduct problems as risk factors for adolescent development. J Am Acad Child Adolesc Psychiat 1996; 35: 1213-1216.
58. Mannuzza S, Klein RG, Bessler A et al. Adult psychiatric status of hyperactive boys grown up. Am J Psychiat 1993; 155: 493-498.
59. Sergeant JA, Steinhausen H-C. European perspective on hyperkinetic disorder. Eur J Child Psychiat 1992; 1: 34-41.
60. Taylor E, Sergeant J, Doepfner M et al. Clinical guidelines for hyperkinetic disorder. European society for child and adolescent psychiatry. Eur Child Adolesc Psychiat 1998; 7: 184-200.
61. Gillberg C, Melander H, von Knorring A-L et al. Long-term stimulant treatment of children with attention deficit hyperactivity symptoms. Arch Gen Psychiat 1997; 54: 857-864.
62. Elia J, Ambrosini PJ, Rapoport JL. Treatment of attention deficit hyperactivity disorder. New Engl J Med 1999; 340: 780-788.
63. Dulcan M and the Work Group on Quality Issues. Practice parameters for assessment and treatment of children, adolescent and adults with attention deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiat 1997; 36 (Suppl) 85S-121S.
64. Richter JE, Arnold LE, Jensens et al. NIMH collaborative multisite, multimodal treatment study of children with ADHD; I. Background and rationale. J Am Acad Child Adolesc Psychiat 1995; 34: 987-1000.
65. MTA cooperative group-A randomized clinical trial of treatment strategies for attention deficit hyperactivity disorder (ADHD). Arch Gen Psychiat 1999; 56: 1073-1086.
66. Butcher SP, Liptrot J, Aburthnott GW. Characterization of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis. Neurosci Lett 1991; 122: 245-248.
67. Gadow KD, Nohal EE, Sverd J, Sprakkin J, Paolicelli L. Methylphenidate in aggressive-hyperactive boys: I. Effects on peer aggression in public school settings. J Am Acad Child Adolesc Psychiat 1990; 29: 710-715.
68. Schachar R, Taylor E, Wieselberg M, Thorley G, Rutter M. Changes in family function and relationships in children who respond to methylphenidate. J Am Acad Child Adolesc Psychiat 1987; 26: 728-732.
69. Klorman R, Brugmaghim JT, Fitzpatrick PA, Borgstedt AD. Methylphenidate speeds evaluation processes of attention deficit disorder adolescents during continuous performance test. J Abnorm Child Psychol 1991; 19: 263-283.
70. O'Toole K, Abramowitz A, Morris R, Dulcan M. Effects of methylphenidate on attention and non-verbal learning in children with ADHD. J Am Acad Child Adolesc Psychiat 1993; 36: 531-538.
71. Barkley RA, McMurray MB, Edelbroch CS, Robbins K. Side-effects of methylphenidate in children with ADHD: Systemic, placebo-controlled evaluation. Pediatrics 1990; 86: 184-192.
72. Elia J, Borcherding BG, Rapoport JL, Keysor CS. Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true non-responders? Psychiat Res 1991; 36: 141-155.
73. Volkow ND, Ding J-S, Fowler JS et al. Is methylphenidate like cocaine? studies on their pharmacokinetics and distribution in human brain. Arch Gen Psychiat 1995; 52: 456-463.
74. Spencer T, Biederman J, Wilens T. Growth deficits in children with attention deficit hyperactivity disorder. Pediatrics 1998; 102: 501-506.
75. Pelham WE, Greenslade KE, Vodde-Hamilton M, et al. Relative efficacy of long-acting stimulants on children with ADHD: A comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline. Pediatrics 1990; 86: 226-237.
76. Popper CW. Combining methylphenidate and clonidine: Pharmacologic and news reports about sudden death. J Child Adolesc Psychopharmacol 1995; 5: 157-166.
77. Varley CK, McClellan J. Case study: Two additional sudden deaths with tricyclic antidepressants. J Am Acad Child Adolesc Psychiat 1997; 36: 390-394.
78. Spencer T, Biederman J, Wilens T et al Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiat 1996; 35: 409-432.
79. Kumra S, Frazier JA, Jacobsen LK et al. Childhood-onset schizophrenia: A double blind clozapine-haloperidol comparison. Arch Gen Psychiat 1996; 53: 1090-1097.
80. Armenteros JL, Witacker AH, Welikson M et al. Risperidone in adolescents with schizophrenia: An open pilot study. J Am Acad Child Adolesc Psychiat 1996; 36: 694-700.
81. Zuddas A, Pintor M, Cianchetti C. Risperidone for negative symptoms. J Am Acad Child Adolesc Psychiat 1996; 35: 838-839.
82. Zuddas A, Ledda MG, Fratta A et al. Clinical effects of clozapine on autistic disorder. Am J Psychiat 1996; 153: 738.
83. Zuddas A, Cianchetti C. Efficacy of risperidone in idiopathic segmental dystonia. Lancet 1996; 347: 127-128.
84. Potenza MN, Holmes JP, Kanes SJ, McDougle CJ. Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: An open-label pilot study. J Clin Psychopharmacol 1999; 19: 37-44.
85. Jensen PS, Mrazek D, Knapp PK et al. Evolution and revolution in child psychiatry: ADHD as a disorder of adaptation. J Am Acad Child Adolesc Psychiat 1997; 36: 1672-1679.
86. Levy F, Hay DA, McStephen M et al. Attention-deficit hyperactivity disorder: A category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiat 1997; 36: 737-744.
87. Ebstein RP, Novick O, Umansky R et al. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nature Genet 1996; 12: 78-80.
88. Benjamin J, Li L, Patterson C et al. Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nature Genet 1996; 12: 81-84.
89. Schachar R, Icowicz A, Tannock R. Parent Interview for Children Symptoms (PICS-4). Toronto: Dept. Psychiatry, Hospital for Sick Children, 1996.